title: Rebamipide protects against activation of neutrophils by Helicobacter pylori.
abstract: Our objectives were to determine whether rebamipide, a unique antiulcer agent, would inhibit adhesive reactions between neutrophils and endothelial cells as well as the production of active oxygen species from neutrophils elicited by an extract of H. pylori. A water extract of H. pylori that was prepared from biopsy materials obtained from a patient with gastric ulcer increased the surface expression of CD18 on human neutrophils isolated from peripheral blood, the adhesion of neutrophil-endothelial cells, and the production of active oxygen species by neutrophils. Rebamipide, at concentrations of 10(-5) and 10(-6) M, reduced the adherence of neutrophils to endothelial cells as well as the CD18 expression on neutrophils induced by this bacterial extract. Rebamipide also inhibited the production of active oxygen species from neutrophils stimulated by H. pylori extract. These results suggest that rebamipide protects against the gastric mucosal inflammation associated with H. pylori by inhibiting neutrophil function.
authors.affiliation: First Department of Internnal Medicine, Kyoto Prefectural University of Medicine, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Yoshida
authors.forename: T
authors.initials: T
authors.lastname: Yoshikawa
authors.forename: S
authors.initials: S
authors.lastname: Iinuma
authors.forename: M
authors.initials: M
authors.lastname: Arai
authors.forename: S
authors.initials: S
authors.lastname: Takenaka
authors.forename: K
authors.initials: K
authors.lastname: Sakamoto
authors.forename: T
authors.initials: T
authors.lastname: Miyajima
authors.forename: Y
authors.initials: Y
authors.lastname: Nakamura
authors.forename: N
authors.initials: N
authors.lastname: Yagi
authors.forename: Y
authors.initials: Y
authors.lastname: Naito
authors.forename: F
authors.initials: F
authors.lastname: Mukai
authors.forename: M
authors.initials: M
authors.lastname: Kondo
mesh_terms: D000409:Alanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D018821:CD18 Antigens / Q000032:analysis; D002448:Cell Adhesion; D004578:Electron Spin Resonance Spectroscopy; D004730:Endothelium, Vascular / Q000502:physiology; D005434:Flow Cytometry; D016480:Helicobacter pylori / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D018375:Neutrophil Activation / Q000187:drug effects; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism; D015363:Quinolones / Q000494:pharmacology*; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D000897:Anti-Ulcer Agents; D018821:CD18 Antigens; D015363:Quinolones; D017382:Reactive Oxygen Species; C052785:rebamipide; D000409:Alanine